Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experience.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 21683302)

Published in J Crohns Colitis on March 10, 2011

Authors

Michael B Sprakes1, P John Hamlin, Lisa Warren, Dan Greer, Alexander C Ford

Author Affiliations

1: Leeds Gastroenterology Institute, Leeds General Infirmary, Leeds, LS1 3EX, United Kingdom. Michael.sprakes@leedsth.nhs.uk

Articles by these authors

Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol (2012) 4.78

Functional Dyspepsia. N Engl J Med (2015) 3.66

Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol (2012) 2.46

Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol (2011) 2.19

Association between constipation and colorectal cancer: systematic review and meta-analysis of observational studies. Am J Gastroenterol (2013) 2.18

Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol (2011) 2.04

Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial). BMJ (2008) 1.98

Initial management of dyspepsia in primary care: an evidence-based approach. Br J Gen Pract (2013) 1.90

Direction of the brain--gut pathway in functional gastrointestinal disorders. Gut (2012) 1.43

Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease. Gut (2010) 1.41

Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis. Am J Gastroenterol (2012) 1.32

Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol (2011) 1.24

Losses to follow-up limit conclusions regarding the efficacy of branched-chain amino acids in patients with hepatic encephalopathy. Am J Gastroenterol (2011) 1.09

Prevalence of irritable bowel syndrome-type symptoms in patients with celiac disease: a meta-analysis. Clin Gastroenterol Hepatol (2012) 1.06

Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis. J Crohns Colitis (2013) 1.04

Prevalence of gastro-esophageal reflux-type symptoms in individuals with irritable bowel syndrome in the community: a meta-analysis. Am J Gastroenterol (2012) 0.96

Ultrasound-Guided Thoracic Paravertebral Blockade: A Retrospective Study of the Incidence of Complications. Anesth Analg (2016) 0.90

Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey. Scand J Gastroenterol (2015) 0.89

Diagnosis and treatment of irritable bowel syndrome. Discov Med (2011) 0.88

An electronic checklist improves transfer and retention of critical information at intraoperative handoff of care. Anesth Analg (2015) 0.88

Use of preoperative paravertebral block decreases length of stay in patients undergoing mastectomy plus immediate reconstruction. Ann Surg Oncol (2012) 0.82

Symptom-based diagnostic criteria for irritable bowel syndrome: the more things change, the more they stay the same. Gastroenterol Clin North Am (2011) 0.82

Redundant data in the meta-analysis on Helicobacter pylori eradication. Ann Intern Med (2009) 0.82

Sinonasal myxoma: a pediatric case. J Pediatr Hematol Oncol (2005) 0.81

Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents. Therap Adv Gastroenterol (2011) 0.80

Efficacy of infliximab in acute severe ulcerative colitis: a single-centre experience. World J Gastroenterol (2013) 0.79

Efficacy of traditional chinese medicine in functional constipation. Am J Gastroenterol (2011) 0.78

Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn's disease: a large single centre experience. J Crohns Colitis (2011) 0.78

Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials. Dis Colon Rectum (2009) 0.78

Long-term efficacy and safety of azathioprine in ulcerative colitis. J Crohns Colitis (2015) 0.77

Psychiatric symptoms and histories among people detained in police cells. Soc Psychiatry Psychiatr Epidemiol (2010) 0.77

Lipid resuscitation: listening to our patients and learning from our models. Anesth Analg (2012) 0.77

Linaclotide: new mechanisms and new promise for treatment in constipation and irritable bowel syndrome. Ther Adv Chronic Dis (2013) 0.76

"Power" of selective serotonin reuptake inhibitors in irritable bowel syndrome. Clin Gastroenterol Hepatol (2009) 0.76

Breath testing and antibiotics for possible bacterial overgrowth in irritable bowel syndrome. Expert Rev Anti Infect Ther (2010) 0.75

Bran and irritable bowels. Bran's deleterious effects: much ado about nothing. BMJ (2009) 0.75

The American College of Gastroenterology irritable bowel syndrome monograph: translating systematic review data to clinical practice. Gastroenterology (2009) 0.75

Disease activity and venous thromboembolism in inflammatory bowel disease. Lancet (2010) 0.75

Helicobacter pylori eradication. Lancet (2011) 0.75

Is the benefit of granulocyte monocyte adsorptive apheresis in ulcerative colitis overstated? Dig Dis Sci (2010) 0.75

Clopidogrel with or without omeprazole in coronary disease. N Engl J Med (2011) 0.75

VSL#3 and remission in active ulcerative colitis: larger studies required. Am J Gastroenterol (2011) 0.75

Functional Dyspepsia. N Engl J Med (2016) 0.75

Treatment of Helicobacter pylori in Latin America. Lancet (2012) 0.75

Lipid emulsion and recovery from local anesthetic-induced "cardiac arrest": misleading interpretations. Anesth Analg (2010) 0.75

Reply to Machicado JD, Villafuerte-Galvez J, Marcos LA, Prevalence of irritable bowel syndrome in South America. Clin Gastroenterol Hepatol (2012) 0.75

Treatment of chronic gastro-oesophageal reflux disease. BMJ (2009) 0.75

GERD: Is laparoscopic surgery cost-effective? Nat Rev Gastroenterol Hepatol (2009) 0.75

Don't forget about constipation with opioid treatment of chronic non-cancer pain. BMJ (2013) 0.75

Utility of fecal calprotectin in differentiating active inflammatory bowel disease from coexistent irritable bowel syndrome. Am J Gastroenterol (2011) 0.75

Overlap among the functional gastrointestinal disorders. Am J Gastroenterol (2010) 0.75

A patient with chronic diarrhea of unknown cause. Clin Gastroenterol Hepatol (2012) 0.75

Faecal microbiota transplantation for <em>Clostridium difficile</em>-associated diarrhoea: a systematic review of randomised controlled trials. Med J Aust (2017) 0.75

Constipation in adults. BMJ Clin Evid (2015) 0.75

Symbiotics in irritable bowel syndrome--better than probiotics alone? Curr Opin Clin Nutr Metab Care (2015) 0.75

Ultrasound-guided interscalene blocks. J Ultrasound Med (2012) 0.75

Localized virtual patient model for regional anesthesia simulation training system. Stud Health Technol Inform (2007) 0.75

The Glasgow Prognostic Score at the Time of Palliative Esophageal Stent Insertion is a Predictive Factor of 30-Day Mortality and Overall Survival. J Clin Gastroenterol (2016) 0.75

Ongoing Symptoms in Ulcerative Colitis Patients in Remission: Irritable Bowel Syndrome or Gastrointestinal Symptoms in the Absence of Inflammation? Inflamm Bowel Dis (2016) 0.75

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large cell B-cell non-Hodgkin's lymphoma. Biol Blood Marrow Transplant (2003) 0.75

Infliximab Therapeutic Drug Monitoring Changes Clinical Decisions in a Virtual Biologics Clinic for Inflammatory Bowel Disease. Inflamm Bowel Dis (2017) 0.75

Image of the month. Autoimmune pancreatitis. Gastroenterology (2005) 0.75